Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Different Frames of Numerical Information in Cochrane Plain Language Summaries

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03554252
Recruitment Status : Completed
First Posted : June 13, 2018
Last Update Posted : September 25, 2018
Sponsor:
Information provided by (Responsible Party):
University of Split, School of Medicine

Brief Summary:
Participants will be randomly given one of two formats containing descriptions of health interventions. In one format, participants will have to read short summaries where results of the intervention are presented as frequencies and the side effects of health intervention are presented as percentages, while in another format the frames will be reversed (results will be presented as percentages and side effects as frequencies). After reading, participants will be asked several questions about the content of the summary and its conclusions.

Condition or disease Intervention/treatment Phase
Health Knowledge, Attitudes, Practice Other: Frequencies Other: Percentages Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 225 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Other
Official Title: Comparison of Different Frames of Numerical Information in Cochrane Plain Language: Randomized Controlled Trial
Actual Study Start Date : April 1, 2018
Actual Primary Completion Date : August 1, 2018
Actual Study Completion Date : August 1, 2018

Arm Intervention/treatment
Experimental: Frequencies Other: Frequencies
Results are presented as natural frequencies (e.g. the drug was effective for 1 out of 10 people) while side effects are presented as percentages (e.g. 40% participants experienced severe side effects)

Experimental: Percentages Other: Percentages
Results are presented as percentages (e.g. the drug was effective for 10% of people) while side effects are presented as natural frequencies (e.g. 4 out of 10 participants experienced severe side effects)




Primary Outcome Measures :
  1. Understanding [ Time Frame: 3 months ]
    Number of the correct answers about the content of the summary, which will consist of four multiple choice questions (with four possible answers where only one is correct, for each question) about the text the participants are reading. Questions will be developed by research team and revised by expert in health communication. The scale ranges from 0-4, where greater score indicates better understanding of the material.


Secondary Outcome Measures :
  1. Attitudes towards the appropriateness of this type of presentation of health information [ Time Frame: 3 months ]
    Likert type scale from 1-10 (1 indicating low appropriateness and 10 would be completely appropriate presentation)

  2. Health numeracy [ Time Frame: 3 months ]
    5 questions about the numerical tasks placed in medical content, total score is number of correct answers on those questions. The five questions are part of Numeracy Understanding in Medicine Instrument (Schapira et al, 2012), and we will translate only the questions focusing on Probability section. Cronbach's alpha in previous research was 0.86 (Schapira et al, 2012). The questions will be revised by independent translator and back translated to English. The scale range is from 0-5, where higher score indicates higher numeracy levels.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients who are visiting their family doctor, and are at least 18 old. Students of biomedical studies at University of Split School of Medicine, who are at least 18 years old.

Exclusion Criteria:

  • Participants younger than 18 years.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03554252


Locations
Layout table for location information
Croatia
University of Split School of Medicine
Split, Croatia, 21000
Sponsors and Collaborators
University of Split, School of Medicine
Investigators
Layout table for investigator information
Principal Investigator: Ivan Buljan, MPsy PhD student
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University of Split, School of Medicine
ClinicalTrials.gov Identifier: NCT03554252    
Other Study ID Numbers: 214-09-7672
First Posted: June 13, 2018    Key Record Dates
Last Update Posted: September 25, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No